XML 33 R17.htm IDEA: XBRL DOCUMENT v3.19.1
Accounts Payable and Accrued Liabilities
12 Months Ended
Dec. 31, 2018
Payables And Accruals [Abstract]  
Accounts Payable and Accrued Liabilities

 


Note 10—Accounts payable and accrued liabilities:

 

 

  

December 31,

 

 

  

2017

 

  

2018

 

 

  

(In millions)

 

Accounts payable:

  

 

 

 

  

 

 

 

Kronos

  

$

107.9

  

  

$

103.2

  

CompX

  

 

2.3

  

  

 

3.2

  

BMI/LandWell

  

 

3.7

  

  

 

2.9

  

NL

  

 

1.8

  

  

 

1.6

  

Other

  

 

.4

  

  

 

.6

  

Total

  

$

116.1

  

  

$

111.5

  

Current accrued liabilities:

  

 

 

 

  

 

 

 

Employee benefits

  

$

36.3

  

  

$

37.5

  

Accrued sales discounts and rebates

  

 

14.3

  

  

 

29.7

 

Deferred income

  

 

28.3

  

  

 

28.3

  

Environmental remediation and related costs

  

 

6.8

  

  

 

6.5

  

Interest

 

 

5.5

 

 

 

5.2

 

Other

  

 

33.6

  

  

 

33.6

  

Total

  

$

124.8

  

  

$

140.8

  

Noncurrent accrued liabilities:

  

 

 

 

  

 

 

 

Other postretirement benefits

  

$

11.3

 

 

$

10.3

 

Reserve for uncertain tax positions

  

 

16.5

  

  

 

19.1

  

Deferred income

  

 

15.7

  

  

 

15.8

 

Employee benefits

  

 

8.4

  

  

 

7.1

  

Insurance claims and expenses

  

 

9.1

  

  

 

8.1

  

Deferred payment obligation

  

 

9.3

  

  

 

9.6

  

Accrued development costs

  

 

6.1

  

  

 

7.5

  

Other

  

 

8.5

  

  

 

9.9

  

Total

  

$

84.9

  

  

$

87.4

  

The risks associated with certain of our accrued insurance claims and expenses have been reinsured, and the related IBNR receivables are recognized as noncurrent assets to the extent the related liability is classified as a noncurrent liability. See Note 7. Our reserve for uncertain tax positions is discussed in Note 14.

Prior to 2016, and in conjunction with the acquisition of a controlling interest of our Real Estate Management and Development Segment, we issued a face value $11.1 million deferred payment obligation owed to NERT that bears interest at 3% per annum, commencing in December 2023, and is collateralized by the BMI and LandWell interests acquired. The deferred payment obligation has no specified maturity date. We are required to make repayments on the deferred payment obligation, in specified amounts, whenever we receive distributions from BMI and LandWell, and we may make voluntary repayments on the deferred payment obligation at any time, in each case without any penalty, but in any case only after our promissory note payable to NERT (discussed in Note 9) has been repaid in full. For financial reporting purposes, the obligation was recorded at its acquisition date present value using a 3% discount rate from December 2023 (when it becomes interest bearing at 3%).